A higher proportion of females carrying the NFKB1 -94 Ins polymorphism were in stage I/II than in stage III/IV (84.4% vs. 15.6%, respectively); tumor sizes also presented similar results (≤T2 vs. >T2; 87.5% vs. 12.5%, respectively) (Table 4). Here, NFKB1 is linked to neoplasm.